(Q40619262)

22 September 2017

Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study (English)

1 reference

22 September 2017

Housman TS

1

1 reference

22 September 2017

Patel MJ

2

1 reference

22 September 2017

Camacho F

3

1 reference

22 September 2017

Feldman SR

4

1 reference

22 September 2017

Fleischer AB Jr

5

1 reference

22 September 2017

Balkrishnan R

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

British Journal of Dermatology

22 September 2017

1 reference

22 September 2017

147

1 reference

22 September 2017

6

1 reference

22 September 2017

1192-1198

1 reference

The epidemiology and experience of atopic eczema during childhood: a discussion paper on the implications of current knowledge for health care, public health policy and research

22 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05031.X

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05031.X

First experience of topical SDZ ASM 981 in children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05031.X

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05031.X

The self-administered psoriasis area and severity index is valid and reliable

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05031.X

Patient measurement of psoriasis disease severity with a structured instrument

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05031.X

Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self-administered psoriasis area severity index scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05031.X

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05031.X

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05031.X

Quantification of the Extent and the Severity of Atopic Dermatitis: The ADASI Score

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05031.X

10.1046/J.1365-2133.2002.05031.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference